We are live on
!
Find out more
JSP
Jackson Square Partners Portfolio holdings
AUM
$247M
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter
Est. Return
+5.21%
1 Year Est. Return
+20.29%
3 Year Est. Return
+101.87%
5 Year Est. Return
+75.18%
10 Year Est. Return
+392.81%
AUM
$26.1B
AUM Growth
+$718M
(+2.8%)
Cap. Flow
-$44.3M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
39.13%
Holding
72
New
8
Increased
28
Reduced
33
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$800M |
| 2 |
Bausch Health
BHC
|
+$643M |
| 3 |
TripAdvisor
TRIP
|
+$442M |
| 4 |
Biogen
BIIB
|
+$409M |
| 5 |
Qualcomm
QCOM
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.33B |
| 2 |
EOG Resources
EOG
|
+$383M |
| 3 |
Crown Castle
CCI
|
+$284M |
| 4 |
Intuit
INTU
|
+$281M |
| 5 |
Microsoft
MSFT
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.37% |
| 2 | Consumer Discretionary | 20.58% |
| 3 | Technology | 15.45% |
| 4 | Communication Services | 12.1% |
| 5 | Financials | 11.94% |
Similar funds
OIA
SRC
TCB
MTWM
SSW
WS
FC
KSWA
Jackson Square Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Jackson Square Partners held 72 positions worth $26.1B, up 2.8% from $25.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jackson Square Partners's Q1 2015 filing shows 8 new, 28 increased, 33 reduced and 3 closed positions. Its largest new stake was Allergan plc: 2,805,318 shares worth $835M. The largest sale was Allergan Inc, an estimated $1.33B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jackson Square Partners's largest Q1 2015 buy was Allergan plc: 2,805,318 shares worth $835M.
- Jackson Square Partners added most to Qualcomm in Q1 2015, an estimated $324M increase.
- Jackson Square Partners's biggest Q1 2015 reduction was EOG Resources, cutting an estimated $383M.
- Jackson Square Partners fully exited Allergan Inc in Q1 2015, selling an estimated $1.33B.
- Jackson Square Partners's ten largest holdings make up 39% of its $26.1B portfolio in Q1 2015.
- Jackson Square Partners opened 8 new positions and closed 3 in Q1 2015.
- Jackson Square Partners's portfolio value rose 2.8% quarter-over-quarter to $26.1B.
Based on Jackson Square Partners's 13F filing for Q1 2015, filed 8 May 2015.